Hormone replacement therapy and cardiovascular disease

International Journal of Gynecology and Obstetrics

Volumn 52, Issue 2, 1996, Pages 119-125

  Gupta, S ^a   Rymer, J ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Hormone replacement therapy

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; NORETHISTERONE; TIBOLONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTERY TONE; BLOOD CLOTTING; BLOOD FLOW; BLOOD PRESSURE; CORONARY RISK; ESTROGEN THERAPY; FEMALE; HEART PROTECTION; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN METABOLISM; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; OBESITY; POSTMENOPAUSE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030060452     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/0020-7292(95)02576-6     Document Type: Review

References (50)

1. OPCS mortality survey. In: Mortality statistics. Series no. 17. London: Department of Health, 1990.
2. Meade TW, Berra H. Hormone replacement therapy and cardiovascular disease. Br Med Bull 1992; 48: 276-308.
3. Wilkes HC, Meade TW. HRT in general practice - a survey of doctors in the MRC's general practice research framework. Br Med J 1991; 302: 1317-1320.
4. Harris RB, Laws A, Reddy VM. Are women using postmenopausal estrogens? A community survey. Am J Public Health 1990; 80: 1266-1268.
5. Stevenson JC, Crook D, Godsland IF. Effects of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993; 98: 83-90.
6. Heinrech J, Sandkamp M, Kokott R et al. Relationship of lipoprotein (a) variables of coagulation and fibrinolysis in a healthy population. Clin Chem 1991; 37: 1950-1954.
7. Utterman G. The mysteries of lipoprotein (a). Science 1989; 264: 904-910.
8. Bass KM, Neuschafler CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 1992; 153: 2209-2216.
9. Ley CJ, Lees B, Stevenson JC. Sex and menopause associated changes in body fat distribution. Am J Clin Nutr 1993; 55: 950-954.
10. Walton C, Godsland IF, Proulder AJ et al. The effects of age and menopause on insulin sensitivity, secretion and elimination in non obese healthy women. Eur J Clin Invest 1993; 23: 466-473.
11. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
12. Gangar KF, Vyas S, Whitehead MI et al. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991; 335: 1470-1471.
13. Jackson RA. Mechanism of age related glucose intolerance. Diabetes Care 1990; 13: 9-19.
14. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary artery disease: a quantitative assessment of the epidemiological evidence. Prev Med 1991; 20: 47-63.
15. Gordan T, Kennel WB, Hkjartland MC et al. Menopause and coronary artery disease: the Framingham study. Ann Intern Med 1978; 89: 157.
16. Eaker ED, Gambon RJ, Castelli WP. Risk factors for coronary heart disease among women: 30 years of follow up from the Framingham study. Presented at: American Heart Association 25th annual conference on cardiovascular disease epidemiology, Tuscany, Arizona, 7-9 March 1985.
17. Sullivan JM, Zwaag RV, Hughes JP et al. Estrogen replacement therapy and coronary artery disease. Arch Intern Med 1990; 150: 2557-2562.
18. Hong MK, Romm PA, Reagan K, Green CE. Effect of estrogen replacement therapy on serum lipid values and angiographically designed coronary artery disease in postmenopausal women. Am J Cardiol 1992; 69: 176-178.
19. Robinson JG, Leon AS. Lipid disorders - the secondary prevention of cardiovascular disease. Med Clin North Am 1994; 78: 1.
20. Mishell DR Jr, Menopause: physiology and pharmacology. Chicago: Year Book Medical Publications. 1987; 121-36.
21. Cust MP. A risk benefit assessment of oestrogen therapy. Drug Saf 1990; 5: 345-358.
22. Walsh BW, Schiff I, Rosner B et al. Effects of postmenopausal estrogen replacement in the case of metabolism and plasma lipoprotein. N Engl J Med 1991; 325: 1196-1204.
23. Mattsson LA, Samsioe G, von Schoultz B, Urebrant M, Wiklund I. Transdermally administered oestradiol with medroxyprogesterone acetate - the effect on lipoprotein metabolism in postmenopausal women. Br J Obstet Gynaecol 1993; 100: 450-453.
24. Ross D, Stevenson JC. Hormone replacement therapy and cardiovascular disease. Br J Sex Med 1993; 20(6): 10-14.
25. Alkjaerseg N, Fletcher AP, Zeigler DC et al. Blood coagulation in postmenopausal women given estrogen treatment: comparison of transdermal and oral administration. J Lab Clin Med 1988; 111: 224-228.
26. Bourne T, Hillard TC, Whitehead MI et al. Oestrogens, arterial status and postmenopausal women. Lancet 1990; 335: 1470-1471.
27. Hillard TC, Bourne TH, Whitehead MI et al. Different effect of transdermal estradiol and sequential progestogen on impedance to flow within uterine artery of postmenopausal women. Fertil Steril 1992; 58: 959-963.
28. Jiang C, Sarrel PM, Lindsay DC et al. Endothelial independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol 1991; 104: 1033-1041.
29. Foidart JM, Dombrowicz N, de Lignieres B. Urinary excretion of prostacycline and thromboxane metabolite in postmenopausal women with percutaneous oestradiol or conjugated oestrogen. In: Dusitsin D et al., editors. Physiological hormone replacement therapy. Carnforth, UK: Parthenon, 1991: 99-107.
30. Sullivan JM. Atherosclerosis and estrogen replacement therapy. Int J Fertil 1994; 39 Suppl 1: 28-35.
31. Maschkak CA, Lobo RA. Estrogen replacement therapy and hypertension. J Reprod Med 1985; 10 (Suppl): 805-810.
32. Cagnacci A, Soldani R, Carnero PL et al. Effect of low dose of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 1992; 74: 1396-1400.
33. Haarbo J, Hassager C, Jansen SB et al. Serum lipids, lipoprotein during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives. Am J Med 1991; 90; 584-589.
34. Jensen J, Riis BJ, Strom V et al. Long term effects of percutaneous estrogen and oral progesterones on serum lipoproteins in postmenopausal women. Am J Obstet Gynecol 1987; 156: 66-71.
35. Kable WT, Gallagher JC, Nastrigall L et al. Lipid changes after hormone replacement therapy for menopause. J Reprod Med 1990; 35: 513-518.
36. Van der Mooren MJ, Dermacker PNM, Thomas CMG et al. Beneficial effects on serum lipoprotein by 17β-oestradiol and dydrogesterone therapy in postmenopausal women. Presented at: 7th international menopause conference, Stockholm, Sweden, 20-24 June 1993.
37. Farisch E, Rolton HA, Barnes JF, Hart DL. Lp(a) concentration in postmenopausal women taking norethisterone. Br Med J 1991; 303: 694.
38. Godsland IF, Crook D, Simpson R et al. The effects of different formulations of combined pill on lipids and carbohydrate metabolism. N Engl J Med 1990; 323: 1375-1381.
39. Falkeborn M, Person I, Lithel H. Oestrogen or Oestrogen Progestin Treatment and Risk of Cardiovascular Diseases. Presented at: 7th international menopause conference, Stockholm, Sweden, 20-24 June 1993.
40. Christiansen C, Riis BJ. Five years with continuous combined therapy. Effects on calcium metabolism, lipoprotein and bleeding pattern. Br J Obstet Gynaecol 1990; 97: 1087-1092.
41. Whitehead MI, Hillard TC, Crook D. The role and use of progestogens. Obstet Gynecol 1990; 75 (Suppl): 595-765.
42. Omodeill SF, Boanti AM. Lipid and lipoprotein modification during sequential vs combined therapy. Presented at: 7th international menopause conference Stockholm, Sweden, 20-24 June 1993.
43. Marsh MS, Cooke D, Ellerington MC, Whitecroft SJ. The effect of continuous oral desogestrel and oestradiol hormone replacement therapy on serum lipids and lipoproteins. Presented at: 7th international menopause conference Stockholm, Sweden, 20-24 June 1993.
44. Speroff L. Controversial issues in menopausal management. In: Year book of obstetrics and gynecology. St Louis, MO: Mosby, 1993: 21-40.
45. Bendeck Jazzman LJ. Long term placebo controlled efficacy and safety studies of Org OD14 in climacteric women. Maturitas 1987; 1 (Suppl): 25-33.
46. Rymer J, Crook D, Sidhu M et al. Effects of tibolone on serum concentrations of lipoprotein (a) in postmenopausal women. Acta Endocrinol 1993; 128: 259-262.
47. Seeley T. Oestrogen replacement therapy following hysterectomy. Br J Sex Med 1993; Aug: 7-9.
48. Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987; 47: 94-100.
49. Jacobs HS, Loeffler FE. Postmenopausal hormone replacement therapy. Br Med J 1992; 305: 1403-1408.
50. Rees T. Menstrual bleeding with hormone replacement therapy. Lancet 1994; 343: 250.